CLINICAL_TRIALS
ClinicalTrials.gov record update
A Non-Inferiority Study of Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02584309
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:29.417764+00:00
- Published At
- 2023-11-07T00:00:00+00:00
- Record Updated At
- 2023-11-07
- Results Posted At
- 2023-11-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Sarcoma, Soft Tissue", "Soft Tissue Sarcoma", "Undifferentiated Pleomorphic Sarcoma", "Leiomyosarcoma", "Liposarcoma", "Synovial Sarcoma", "Myxofibrosarcoma", "Angiosarcoma", "Fibrosarcoma", "Malignant Peripheral Nerve Sheath Tumor", "Epithelioid Sarcoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-11-07"- protocolSection.identificationModule.nctId
"NCT02584309"- protocolSection.identificationModule.officialTitle
"A Non-Inferiority Study of Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-11-07"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.